Technology | March 11, 2010

New PET/CT Targets Radiology, Oncology Needs

March 11, 2010 - A new PET/CT (postitron emission tomography/computed tomography) system provides imaging for both the clinical areas of both radiology and oncology.

Launched at the European Congress of Radiology (ECR 2010), the GEMINI LXL is designed to help optimize workflow and streamline operations. Featured in the GEMINI LXL are workflow improvements and the availability of a couch motion enabler. Streamlined workflow is also included for cardiac scanning, from easier cardiac gating setup and data storage to a cardiac alignment application which simplifies the process of cardiac re-alignment.

The GEMINI LXL features new crystal and detector technology and is designed with enhanced sensitivity and higher image quality through reconstruction and image processing. It also enables improved accuracy with patient motion management due to its 4D PET/CT imaging capabilities.

Modern crystals and detector technology used for the GEMINI LXL are engineered to improve image quality and lead to a faster output of scans. Not only can it be used for imaging in the oncology field but it can also be adjusted with various cardiac applications such as Emory Cardiac Toolbox and Cedars AutoQuant.

High definition PET reconstruction and 4D PET/CT imaging, which is optional, are included to enhance the image quality, reconstruction and accuracy with patient motion management.

The GEMINI LXL PET / CT scanner will be released in the second quarter of 2010.

For more information: www.medical.philips.com

Related Content

SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
PET/CT Tracer Identifies Vulnerable Lesions in Non-Small Cell Lung Cancer Patients

Example of a patient with an upper left lung NSCLC: A: FDG; B: FDG PET/CT; C: Planning radiotherapy based on FDG (66Gy) with BTVm (GTV), CTV and PTV; D: PET FMISO E: FMISO PET/CT; F: boost based on the FMISO PET (76Gy) with BTVh (biological hypoxic target volume) and PTV boost. Credit: QuantIF – LITIS EA 4108 – FR CNRS 3638, Henri Becquerel Cancer Center, Rouen, France

News | PET-CT | July 14, 2017
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET)...
Overlay Init